I Ray-Coquard1, A L Cesne, J Y Blay. Show Affiliations » 1. Centre Léon-Bérard. 28, rue Laennec, 69008 Lyon, France. ray@lyon.fnclcc.fr
Abstract
Entities: Disease
Mesh： See more » Antineoplastic Agents/adverse effectsAntineoplastic Agents/therapeutic useBenzamidesClinical Trials, Phase I as TopicClinical Trials, Phase II as TopicEnzyme Inhibitors/adverse effectsEnzyme Inhibitors/therapeutic useGastrointestinal Neoplasms/drug therapyHumansImatinib MesylatePiperazines/therapeutic usePyrimidines/therapeutic useSarcoma/drug therapy
Substances： See more » Antineoplastic AgentsBenzamidesEnzyme InhibitorsPiperazinesPyrimidinesImatinib Mesylate
Year: 2001 PMID： 11495818
Source DB: PubMed Journal: Bull Cancer ISSN： 0007-4551 Impact factor: 1.276